Simon Hubbert, Chief Executive of RHYTHM AI Ltd, commented: "We are encouraged to see additional, positive data demonstrating the superior results of STAR Mapping in the treatment of persistent AF, which has historically proved difficult to treat with conventional ablation therapy.